Title:
抗炎症剤の経皮投与用医薬組成物
Document Type and Number:
Japanese Patent JP5149477
Kind Code:
B2
Abstract:
A pharmaceutical composition for transdermal administration comprising a polymeric release matrix capable of forming a supple film after drying, selected among cellulose polymers or copolymers; an active principle selected among the group of non-steroid anti-inflammatory agents comprising at least one carboxylic or metal carboxylate group; a transcutaneous absorption promoter; water; and a physiologically acceptable non-aqueous solvent capable of dissolving the release matrix, the active principle and the transcutaneous absorption promoter and to be rapidly eliminated by evaporation on contact with the skin.
Inventors:
Bridget, Irel
Vergnow, Jean-Pierre
Vergnow, Jean-Pierre
Application Number:
JP2001581797A
Publication Date:
February 20, 2013
Filing Date:
May 11, 2001
Export Citation:
Assignee:
SANOFI
International Classes:
A61K9/70; A61K31/192; A61K47/10; A61K47/14; A61K47/34; A61K47/38; A61P29/00
Domestic Patent References:
| JP1143831A | ||||
| JP6321771A | ||||
| JP4234314A | ||||
| JP11502828A |
Foreign References:
| WO1999022716A1 |
Attorney, Agent or Firm:
Shintaro Nogawa
Previous Patent: JPS5149476
Next Patent: LIGHTWEIGHT SEAM WELDED STEEL PIPE EXCELLENT IN THREE POINT BENDING STRENGTH
Next Patent: LIGHTWEIGHT SEAM WELDED STEEL PIPE EXCELLENT IN THREE POINT BENDING STRENGTH